Early gene expression changes in spinal cord from SOD1G93A amyotrophic lateral sclerosis animal model

Frontiers in Cellular Neuroscience

Volumn 6, Issue NOV, 2013, Pages

  de Oliveira, Gabrieal P ^a   Alves, Chrystian J ^a   Chadi, Gerson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ALS; Astrocytes; Laser microdissection; Microarray; Pre symptomatic; SOD1G93A; Spinal cord

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; RNA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ANTIGEN PRESENTATION; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENDOCYTOSIS; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING; LASER MICRODISSECTION; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SOD1 GENE; SUMOYLATION; SYNAPSE; TIGHT JUNCTION; UBE2I GENE; WILD TYPE;

EID: 84888161010     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00216     Document Type: Article

References (131)

1. Alves, C. J., De Santana, L. P., Dos Santos, A. J., De Oliveira, G. P., Duobles, T., Scorisa, J. M., et al. (2011). Early motor and electrophysio-logical changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 1394, 90-104. doi: 10.1016/j.brainres.20n.02.060
2. Andersen, P. M., and Al-Chalabi, A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 7, 603-615. doi: 10.1038/nrneurol.2011.150
3. Arhart, R. W. (2010). A possible haemodynamic mechanism for amyotrophic lateral sclerosis. Med. Hypotheses 75, 341-346. doi: 10.1016/j.mehy.2010.03.017
4. Basso, M., Samengo, G., Nardo, G., Massignan, T., D'alessandro, G., Tartari, S., et al. (2009). Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PLoS ONE 4:e8130. doi: 10.1371/journal.pone.0008130
5. Beghi, E., Logroscino, G., Chio, A., Hardiman, O., Mitchell, D., Swingler, R., et al. (2006). The epidemiology of ALS and the role of population-based registries. Biochim. Biophys. Acta 1762, 1150-1157. doi: 10.1016/j.bbadis.2006.09.008
6. Bendotti, C., Marino, M., Cheroni, C., Fontana, E., Crippa, V., Poletti, A., et al. (2012). Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Prog. Neurobiol. 97, 101-126. doi: 10.1016/j.pneurobio.2011.10.001
7. Bendotti, C., Tortarolo, M., Suchak, S. K., Calvaresi, N., Carvelli, L., Bastone, A., et al. (2001). Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J. Neurochem. 79, 737-746. doi: 10.1046/j.1471-4159.2001.00572.x
8. Bergeron, C., Beric-Maskarel, K., Muntasser, S., Weyer, L., Somerville, M. J., and Percy, M. E. (1994). Neurofilament light and polyadenylated mRNA levels are decreased in amyotrophic lateral sclerosis motor neurons. J. Neuropathol. Exp. Neurol. 53, 221-230. doi: 10.1097/00005072-199405000-00002
9. Boillee, S., Vande Velde, C., and Cleveland, D. W. (2006a). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39-59. doi: 10.1016/j.neuron.2006.09.018
10. Boillee, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., et al. (2006b). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392. doi: 10.1126/science.1123511
11. Boston-Howes, W., Gibb, S. L., Williams, E. O., Pasinelli, P., Brown, R. H. Jr., and Trotti, D. (2006). Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J. Biol. Chem. 281, 14076-14084. doi: 10.1074/jbc.M600653200
12. Brettschneider, J., Mogel, H., Lehmensiek, V., Ahlert, T., Sussmuth, S., Ludolph, A. C., et al. (2008). Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS). Neurochem. Res. 33, 2358-2363. doi: 10.1007/s11064-008-9742-5
13. Brockington, A., Heath, P. R., Holden, H., Kasher, P., Bender, F. L., Claes, F., et al. (2010). Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis. BMC Genomics 11:203. doi: 10.1186/1471-2164 11-203
14. Brooks, B. R., Miller, R. G., Swash, M., and Munsat, T. L. (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293-299. doi: 10.1080/146608200300079536
15. Bruening, W., Roy, J., Giasson, B., Figlewicz, D. A., Mushynski, W. E., and Durham, H. D. (1999). Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 72, 693-699. doi: 10.1046/j.1471-4159.1999.0720693.x
16. Casas, C., Herrando-Grabulosa, M., Manzano, R., Mancuso, R., Osta, R., and Navarro, X. (2013). Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav 3, 145-158. doi: 10.1002/brb3.104
17. Chen, K., Northington, F. J., and Martin, L. J. (2010). Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice. Brain Struct. Funct. 214, 219-234. doi: 10.1007/s00429-009-0226-4
18. Cheroni, C., Peviani, M., Cascio, P., Debiasi, S., Monti, C., and Bendotti, C.Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiol. Dis. 18, 509-522. doi: 10.1016/j.nbd.2004.12.007
19. Chuaqui, R. F., Bonner, R. F., Best, C. J., Gillespie, J. W., Flaig, M. J., Hewitt, S. M., et al. (2002). Post-analysis follow-up and validation of microarray experiments. Nat. Genet. 32(Suppl.), 509-514. doi:10.1038/ng1034
20. Dallas, P. B., Gottardo, N. G., Firth, M. J., Beesley, A. H., Hoffmann, K., Terry, P. A., et al. (2005). Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR-how well do they correlate? BMC Genomics 6:59. doi:10.1186/1471-2164-6-59
21. Dangond, F., Hwang, D., Camelo, S., Pasinelli, P., Frosch, M. P., Stephanopoulos, G., et al. (2004). Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol. Genomics 16, 229-239. doi: 10.1152/physiolgenomics.00087.2001
22. Dangoumau, A., Veyrat-Durebex, C., Blasco, H., Praline, J., Corcia, P., Andres, C. R., et al. (2013). Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Int. J. Neurosci. 123, 366-374. doi: 10.3109/00207454.2012.761984
23. D'arrigo, A., Colavito, D., Pena-Altamira, E., Fabris, M., Dam, M., Contestabile, A., et al. (2010). Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease? J. Mol. Neurosci. 41, 404-415. doi: 10.1007/s12031-010-9332-2
24. De Oliveira, G. P., Maximino, J. R., Lin, C. J., and Chadi, G. (2009). A method to immunolabel rodent spinal cord neurons and glia for molecular study in specific laser microdissected cells involved in neurodegenerative disorders. J. Mol. Histol. 40, 217-225. doi: 10.1007/s10735-009-9233-2
25. De Winter, F., Vo, T., Stam, F. J., Wisman, L. A., Bar, P. R., Niclou, S. P., et al. (2006).The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell. Neurosci. 32, 102-117. doi: 10.1016/j.mcn.2006. 03.002
26. Dion, P. A., Daoud, H., and Rouleau, G. A. (2009). Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat. Rev. Genet. 10, 769-782. doi: 10.1038/nrg2680
27. Doherty, G. J., and McMahon, H. T. (2009). Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857-902. doi: 10.1146/annurev.biochem.78.081307. 110540
28. Druyan, S., de Oliveira, J. E., and Ashwell, C. M. (2008). Focused microarrays as a method to evaluate subtle changes in gene expression. Poult. Sci. 87, 2418-2429. doi: 10.3382/ps.2007-00513
29. Elmer, B. M., and McAllister, A. K. (2012). Major histocompatibility complex class I proteins in brain development and plasticity. Trends Neurosci. 35, 660-670. doi: 10.1016/j.tins.2012.08.001
30. Fei, E., Jia, N., Yan, M., Ying, Z., Sun, Q., Wang, H., et al. (2006). SUMO-1 modification increases human SOD1 stability and aggregation. Biochem. Biophys. Res. Commun. 347, 406-412. doi: 10.1016/j.bbrc.2006.06.092
31. Ferraiuolo, L., Heath, P. R., Holden, H., Kasher, P., Kirby, J., and Shaw, P. J. (2007). Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. 27, 9201-9219. doi: 10.1523/JNEUROSCI.1470-07.2007
32. Ferraiuolo, L., Higginbottom, A., Heath, P. R., Barber, S., Greenald, D., Kirby, J., et al. (2011a). Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134, 2627-2641. doi: 10.1093/brain/awr193
33. Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., and Shaw, P. J. (2011b). Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 7, 616-630. doi: 10.1038/nrneurol.2011.152
34. Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232-240. doi: 10.1016/j.expneurol.2003.10.004
35. Foran, E., Bogush, A., Goffredo, M., Roncaglia, P., Gustincich, S., Pasinelli, P., et al. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia 59, 1719-1731. doi: 10.1002/glia.21218
36. Garbuzova-Davis, S., Hernandez-Ontiveros, D. G., Rodrigues, M. C., Haller, E., Frisina-Deyo, A., Mirtyl, S., et al. (2012). Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 1469, 114-128. doi: 10.1016/j.brainres.2012.05.056
37. Garbuzova-Davis, S., Rodrigues, M. C., Hernandez-Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., et al. (2011). Amyotrophic lateral sclerosis: a neurovascular disease. Brain Res. 1398, 113-125. doi: 10.1016/j.brainres.2011.04.049
38. Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., et al. (2004). Bioconductor: open software development for computational biology and bioinformatics. GenomeBiol. 5:R80. doi: 10.1186/gb-2004-5-10-r80
39. Gerber, Y. N., Sabourin, J. C., Rabano, M., Vivanco, M., and Perrin, F. E.(2012). Early functional deficit and microglial disturbances in a mouse model of amyotrophic lateral sclerosis. PLoS ONE 7:e36000. doi: 10.1371/jour-nal.pone.0036000
40. Gibb, S. L., Boston-Howes, W., Lavina, Z. S., Gustincich, S., Brown, R. H. Jr., Pasinelli, P., et al. (2007). A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis. J. Biol. Chem. 282, 32480-32490. doi: 10.1074/jbc.M704314200
41. Gifondorwa, D. J., Jimenz-Moreno, R., Hayes, C. D., Rouhani, H., Robinson, M. B., Strupe, J. L., et al. (2012). Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis. Neurol. Res. Int. 2012, 170426. doi: 10.1155/2012/170426
42. Gifondorwa, D. J., Robinson, M. B., Hayes, C. D., Taylor, A. R., Prevette, D. M., Oppenheim, R. W., et al. (2007). Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 27, 13173-13180. doi: 10.1523/JNEUROSCI.4057-07.2007
43. Graber, D. J., Hickey, W. F., and Harris, B. T. (2010). Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J. Neuroinflammation 7, 8. doi: 10.1186/1742-2094-7-8
44. Grammas, P., Martinez, J., and Miller, B. (2011). Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. ExpertRev. Mol. Med. 13, e19. doi: 10.1017/S1462399411001918
45. Guipponi, M., Li, Q. X., Hyde, L., Beissbarth, T., Smyth, G. K., Masters, C. L., et al. (2010). SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. J. Mol. Neurosci. 41, 172-182. doi: 10.1007/s12031-009-9317-1
46. Gupta, P. K., Prabhakar, S., Sharma, N. K., and Anand, A. (2012). Possible association between expression of chemokine receptor-2 (CCR2) and amyotrophic lateral sclerosis (ALS) patients of North India. PLoS ONE 7:e38382. doi: 10.1371/journal.pone.0038382
47. Gurney, M. E. (1994). Transgenic-mouse model of amyotrophic lateral sclerosis. N. Engl. J. Med. 331, 1721-1722. doi: 10.1056/NEJM199412223312516
48. Hall, E. D., Oostveen, J. A., and Gurney, M. E. (1998). Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23, 249-256. doi: 10.1002/(SICI)1098-1136(199807)23:3
49. Heath, P. R., and Shaw, P. J. (2002). Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 26, 438-458. doi: 10.1002/mus.10186
50. Henkel, J. S., Beers, D. R., Siklos, L., and Appel, S. H. (2006). The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 31, 427-437. doi: 10.1016/j.mcn.2005.10.016
51. Henkel, J. S., Beers, D. R., Wen, S., Bowser, R., and Appel, S. H. (2009). Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72, 1614-1616. doi: 10.1212/WNL.0b013e3181a41228
52. Jiang, M., Schuster, J. E., Fu, R., Siddique, T., and Heckman, C. J. (2009). Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 29, 15031-15038. doi: 10.1523/JNEUROSCI.0574-09.2009
53. Jiang, Y. M., Yamamoto, M., Kobayashi, Y., Yoshihara, T., Liang, Y., Terao, S., et al. (2005). Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 57, 236-251. doi: 10.1002/ana.20379
54. Kalathur, R. K., Hernandez-Prieto, M. A., and Futschik, M. E. (2012). Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database. BMCNeurol. 12:47. doi: 10.1186/1471-2377 12-47
55. Kawahara, Y., Ito, K., Sun, H., Ito, M., Kanazawa, I., andKwak, S. (2004). Regulation of glutamate receptor RNA editing and ADAR mRNA expression in developing human normal and Down's syndrome brains. Brain Res. Dev. Brain Res. 148, 151-155. doi: 10.1016/j.devbrainres.2003.11.008
56. Kieran, D., Kalmar, B., Dick, J. R., Riddoch-Contreras, J., Burnstock, G., and Greensmith, L. (2004). Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10, 402-405. doi: 10.1038/nm1021
57. Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., et al. (2011). Amyotrophic lateral sclerosis. Lancet 377, 942-955. doi: 10.1016/S0140-6736(10)61156-7
58. Kimura, T., and Griffin, D. E. (2000). The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J. Virol. 74, 6117-6125. doi: 10.1128/JVI.74.13.6117-6125.2000
59. Kon, M., and Cuervo, A. M. (2010). Chaperone-mediated autophagy in health and disease. FEBSLett. 584, 1399-1404. doi: 10.1016/j.febslet.2009.12.025
60. Koopman, W. J., Distelmaier, F., Smeitink, J. A., and Willems, P. H. (2013). OXPHOS mutations and neurodegeneration. EMBO J. 32, 9-29. doi: 10.1038/emboj.2012.300
61. Kuhle, J., Lindberg, R. L., Regeniter, A., Mehling, M., Steck, A. J., Kappos, L., et al. (2009). Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur. J. Neurol. 16, 771-774. doi: 10.1111/j.1468-1331.2009. 02560.x
62. Kwak, Y. D., Wang, B., Li, J. J., Wang, R., Deng, Q., Diao, S., et al. (2012). Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration. J. Neurosci. 32, 10971-10981. doi: 10.1523/JNEUROSCI.1836-12.2012
63. Lemmens, R., Moore, M. J., Al-Chalabi, A., Brown, R. H. Jr., and Robberecht, W.RNA metabolism and the pathogenesis of motor neuron diseases. Trends Neurosci. 33, 249-258. doi: 10.1016/j.tins.2010.02.003
64. Lenzken, S. C., Romeo, V., Zolezzi, F., Cordero, F., Lamorte, G., Bonanno, D., et al.(2011).Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration. Hum. Mutat. 32, 168-182. doi: 10.1002/humu.21394
65. Le Roy, C., and Wrana, J. L. (2005). Clathrin-and non-clathrin-mediated endo-cytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6, 112-126. doi: 10.1038/nrm1571
66. Lin, J., Diamanduros, A., Chowdhury, S. A., Scelsa, S., Latov, N., and Sadiq, S. A. (2009). Specific electron transport chain abnormalities in amyotrophic lateral sclerosis. J. Neurol. 256, 774-782. doi: 10.1007/s00415-009-5015-8
67. Liu, J. X., Brannstrom, T., Andersen, P. M., and Pedrosa-Domellof, F. (2013). Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles ofALS donors. PLoS ONE 8:e57473. doi: 10.1371/journal.pone.0057473
68. Luo, Y., Xue, H., Pardo, A. C., Mattson, M. P., Rao, M. S., and Maragakis, N. J. (2007). Impaired SDF1/CXCR4 signaling in glial progenitors derived from SOD1(G93A) mice. J. Neurosci. Res. 85,2422-2432. doi: 10.1002/jnr.21398
69. Malaspina, A., and De Belleroche, J. (2004). Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis. Brain Res. BrainRes. Rev. 45, 213-229. doi: 10.1016/j.brainresrev.2004.04.002
70. Manfredi, G., and Xu, Z. (2005). Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5, 77-87. doi: 10.1016/j.mito.2005. 01.002
71. Manzano, R., Toivonen, J. M., Olivan, S., Calvo, A. C., Moreno-Igoa, M., Munoz, M. J., et al. (2011). Altered expression of myogenic regulatory factors in the mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 8, 386-396. doi: 10.1159/000324159
72. Martin, L. J. (2010). Mitochondrial and cell death mechanisms in neurodegenera-tive diseases. Pharmaceuticals (Basel) 3, 839-915. doi: 10.3390/ph3040839
73. Martin, S., Wilkinson, K. A., Nishimune, A., and Henley, J. M. (2007). Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8, 948-959. doi: 10.1038/nrn2276
74. Martin, L. J. (2011). Mitochondrial pathobiology in ALS. J Bioenerg Biomembr 43, 569-579. doi: 10.1007/s10863-011-9395-y.
75. Massey, A. C., Zhang, C., and Cuervo, A. M. (2006). Chaperone-mediated autophagy in aging and disease. Curr. Top. Dev. Biol. 73, 205-235. doi: 10.1016/S0070-2153(05)73007-6
76. Massignan, T., Casoni, F., Basso, M., Stefanazzi, P., Biasini, E., Tortarolo, M., et al. (2007). Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem. Biophys. Res. Commun. 353, 719-725. doi: 10.1016/j.bbrc.2006.12.075
77. Matsumoto, A., Tateishi, Y., Onoyama, I., Okita, Y., Nakayama, K., and Nakayama, K. I. (2011). Fbxw7beta resides in the endoplasmic reticulum membrane and protects cells from oxidative stress. Cancer Sci. 102, 749-755. doi: 10.1111/j.1349-7006.2011.01851.x
78. McMahon, H. T., and Boucrot, E. (2011). Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12, 517-533. doi: 10.1038/nrm3151
79. Miyazaki, K., Ohta, Y., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., et al. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis. J. Neurosci. Res. 89, 718-728. doi: 10.1002/jnr.22594
80. Morimoto, N., Nagai, M., Ohta, Y., Miyazaki, K., Kurata, T., Morimoto, M., et al.(2011). Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. BrainRes. 1167, 112-117. doi: 10.1016/j.brainres.2007.06.045
81. Mougeot, J. L., Li, Z., Price, A. E., Wright, F. A., and Brooks, B. R. (2011). Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway. BMC Med. Genomics 4:74. doi: 10.1186/1755-8794-4-74
82. Narai, H., Manabe, Y., Nagai, M., Nagano, I., Ohta, Y., Murakami, T., et al. (2009). Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation. Neurol. Int. 1:e16. doi: 10.4081/ni.2009.e16
83. Nateri, A. S., Riera-Sans, L., Da Costa, C., and Behrens, A. (2004). The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling. Science 303, 1374-1378. doi: 10.1126/science.1092880
84. Offen, D., Barhum, Y., Melamed, E., Embacher, N., Schindler, C., and Ransmayr, G. (2009). Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J. Mol. Neurosci. 38, 85-93. doi: 10.1007/s12031-007-9004-z
85. Oliveira, A. L., Thams, S., Lidman, O., Piehl, F., Hokfelt, T., Karre, K., et al. (2004). A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomy. Proc. Natl. Acad. Sci. U.S.A. 101, 17843-17848. doi: 10.1073/pnas.0408154101
86. Olsen, M. K., Roberds, S. L., Ellerbrock, B. R., Fleck, T. J., McKinley, D. K., and Gurney, M. E. (2001). Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol. 50, 730-740. doi: 10.1002/ana.1252
87. Otomo, A., Pan, L., and Hadano, S. (2012). Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases. Neurol. Res. Int. 2012, 498-428. doi: 10.1155/2012/498428
88. Pedotti, P., 't Hoen, P. A., Vreugdenhil, E., Schenk, G. J., Vossen, R. H., Ariyurek, Y., et al. (2008). Can subtle changes in gene expression be consistently detected with different microarray platforms? BMC Genomics 9:124. doi: 10.1186/14712164-9-124
89. Perrin, F. E., Boisset, G., Docquier, M., Schaad, O., Descombes, P., and Kato, A. C. No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum. Mol. Genet. 14, 3309-3320. doi: 10.1093/hmg/ddi357
90. Perrin, F. E., Boisset, G., Lathuiliere, A., and Kato, A. C. (2006). Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age. J. Neurochem. 98, 1959-1972. doi: 10.1111/j.1471-4159.2006.04024.x
91. Petri, S., Schmalbach, S., Grosskreutz, J., Krampfl, K., Grothe, C., Dengler, R., et al. (2005). The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice. J. Neurol. Sci. 238, 25-30. doi: 10.1016/j.jns.2005.06.005
92. Polymenidou, M., and Cleveland, D. W. (2011). The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147, 498-508. doi: 10.1016/j.cell.2011.10.011
93. Prifti, E., Zucker, J. D., Clement, K., and Henegar, C. (2008). FunNet: an integrative tool for exploring transcriptional interactions. Bioinformatics 24, 2636-2638. doi: 10.1093/bioinformatics/btn492
94. Rentzos, M., Nikolaou, C., Rombos, A., Boufidou, F., Zoga, M., Dimitrakopoulos, A., et al. (2007). RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 8, 283-287. doi: 10.1080/17482960701419232
95. Richardson, K., Allen, S. P., Mortiboys, H., Grierson, A. J., Wharton, S. B., Ince, P. G., et al. (2013). The effect of SOD1 mutation on cellular bioenergetic profile and viability in response to oxidative stress and influence of mutation-type. PLoS ONE 8:e68256. doi: 10.1371/journal.pone.0068256
96. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. doi: 10.1038/362059a0
97. Rothstein, J. D., Martin, L. J., and Kuncl, R. W. (1992). Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464-1468. doi: 10.1056/NEJM199205283262204
98. Rotshenker, S. (2009). The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease. J. Mol. Neurosci. 39, 99-103. doi: 10.1007/s12031-009-9186-7
99. Sanagi, T., Yuasa, S., Nakamura, Y., Suzuki, E., Aoki, M., Warita, H., et al. (2010). Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J. Neurosci. Res. 88, 2736-2746. doi: 10.1002/jnr.22424
100. Sargsyan, S. A., Blackburn, D. J., Barber, S. C., Monk, P. N., and Shaw, P. J. (2009). Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1. Neuroreport 20, 1450-1455. doi: 10.1097/WNR.0b013e328331e8fa
101. Saris, C. G., Groen, E. J., Koekkoek, J. A., Veldink, J. H., and Van Den Berg, L. H. (2013a). Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: a comparison between transgenic mouse models and human patients. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 177-189. doi: 10.3109/21678421.2012.729842
102. Saris, C. G., Groen, E. J., Van Vught, P. W., Van Es, M. A., Blauw, H. M., Veldink, J. H., et al. (2013b). Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle. Amyotroph. Lateral Scler. Frontotemporal Degener. 14, 190-198. doi: 10.3109/21678421.2012.749914
103. Sasaki, S., Warita, H., Abe, K., Komori, T., and Iwata, M. (2001). EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Neuroreport 12, 1359-1362. doi: 10.1097/00001756-200105250-00014
104. Schutz, B. (2005). Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis. Neurobiol. Dis. 20, 131-140. doi: 10.1016/j.nbd.2005.02.006
105. Scorisa, J. M., Duobles, T., Oliveira, G. P., Maximino, J. R., and Chadi, G. (2010). The review of the methods to obtain non-neuronal cells to study glial influence on Amyotrophic Lateral Sclerosis pathophysiology at molecular level in vitro. Acta Cir. Bras. 25,281-289. doi: 10.1590/S0102-86502010000300011
106. Shideman, C. R., Hu, S., Peterson, P. K., and Thayer, S. A. (2006). CCL5 evokes calcium signals in microglia through a kinase-, phosphoinositide-, and nucleotide-dependent mechanism. J. Neurosci. Res. 83, 1471-1484. doi: 10.1002/jnr.20839
107. Singh, R. K., Cooper, T. A. (2012). Pre-mRNA splicing in disease and therapeutics. TrendsMol. Med. 18, 472-82. doi: 10.1016/j.molmed.2012.06.006
108. Smyth, G. K. (2005). Limma: linear models for microarray data, in Bioinformatics and Computational Biology Solutions using R and Bioconductor, eds V. C. R. Gentleman, S. Dudoit, R. Irizarry, and W. Huber (New York, NY: Springer), 397-420.
109. Sunico, C. R., Dominguez, G., Garcia-Verdugo, J. M., Osta, R., Montero, F., and Moreno-Lopez, B. (2011). Reduction in the motoneuron inhibitory/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. BrainPathol. 21, 1-15. doi: 10.1111/j.1750-3639.2010.00417.x
110. Takeuchi, H., Kobayashi, Y., Yoshihara, T., Niwa, J., Doyu, M., Ohtsuka, K., et al. (2002). Hsp70 and Hsp40 improve neurite outgrowth and suppress intracy-toplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Res. 949, 11-22. doi: 10.1016/S0006-8993(02)02568-4
111. Tateishi, T., Yamasaki, R., Tanaka, M., Matsushita, T., Kikuchi, H., Isobe, N., et al. (2010). CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. J. Neuroimmunol. 222, 76-81. doi: 10.1016/j.jneuroim.2010.03.004
112. Tateno, M., Sadakata, H., Tanaka, M., Itohara, S., Shin, R. M., Miura, M., et al. (2004). Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum. Mol. Genet. 13, 2183-2196. doi: 10.1093/hmg/ddh246
113. Tian, F., Morimoto, N., Liu, W., Ohta, Y., Deguchi, K., Miyazaki, K., et al. (2011). In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis. Autophagy 7, 985-992. doi: 10.4161/auto.7.9.16012
114. Turner, B. J., and Talbot, K. (2008). Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85, 94-134. doi: 10.1016/j.pneurobio.2008.01.001
115. Turner, M. R., Hardiman, O., Benatar, M., Brooks, B. R., Chio, A., De Carvalho, M., et al. (2013). Controversies and priorities in amyotrophic lateral sclerosis. LancetNeurol. 12, 310-322. doi: 10.1016/S1474-4422(13)70036-X
116. Urushitani, M., Kurisu, J., Tateno, M., Hatakeyama, S., Nakayama, K., Kato, S., et al. (2004). CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J. Neurochem. 90, 231-244. doi: 10.1111/j.1471-4159.2004.02486.x
117. Usuki, S., Kamitani, T., Matsuo, Y., and Yu, R. K. (2012). Pathobiochemical effect of acylated steryl-beta-glucoside on aggregation and cytotoxicity of alpha-synuclein. Neurochem. Res. 37, 1261-1266. doi: 10.1007/s11064-011-0662-4
118. Van Gelder, R. N., Von Zastrow, M. E., Yool, A., Dement, W. C., Barchas, J. D., and Eberwine, J. H. (1990). Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. U.S.A. 87, 1663-1667. doi: 10.1073/pnas.87.5.1663
119. Veugelers, B., Theys, P., Lammens, M., Van Hees, J., and Robberecht, W. (1996). Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block. J. Neurol. Sci. 136, 64-70. doi: 10.1016/0022-510X(95)00295-D
120. Wang, L., Gutmann, D. H., and Roos, R. P. (2011a). Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum. Mol. Genet. 20, 286-293. doi: 10.1093/hmg/ddq463
121. Wang, R., Yang, B., and Zhang, D. (2011b). Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model. Glia 59, 946-958. doi: 10.1002/glia.21167
122. Weydt, P., Weiss, M. D., Moller, T., and Carter, G. T. (2002). Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosis. Curr. Opin. Investig. Drugs 3, 1720-1724. doi: 10.1016/0022-510X(95)00295-D
123. Wootz, H., Enjin, A., Wallen-Mackenzie, A., Lindholm, D., and Kullander, K. (2010). Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice. Neurobiol. Dis. 37, 58-66. doi: 10.1016/j.nbd.2009. 09.006
124. Xu, R., Wu, C., Zhang, X., Zhang, Q., Yang, Y., Yi, J., et al. (2011). Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS. Brain Res. 1372, 133-144. doi: 10.1016/j.brainres.2010.11.056
125. Yamamoto, M., Tanaka, F., and Sobue, G. (2007). [Gene expression profile of spinal ventral horn in ALS]. Brain Nerve 59, 1129-1139
126. Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., et al. (2008). Astrocytes as determinants of disease progresssion in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 11, 251-253. doi: 10.1038/nn2047
127. Yoshihara, T., Ishigaki, S., Yamamoto, M., Liang, Y., Niwa, J., Takeuchi, H., et al. (2002). Differential expression of inflammation-and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80, 158-167. doi: 10.1046/j.0022-3042.2001.00683.x
128. Yu, L., Guan, Y., Wu, X., Chen, Y., Liu, Z., Du, H., et al. (2013). Wnt signaling is altered by spinal cord neuronal dysfunction in amyotrophic lateral sclerosis transgenic mice. Neurochem. Res. 38, 1904-1913. doi: 10.1007/s11064-013-1096-y
129. Zhang, R., Gascon, R., Miller, R. G., Gelinas, D. F., Mass, J., Lancero, M., et al. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 179, 87-93. doi: 10.1016/j.jneuroim.2006.06.008
130. Zhao, P., Ignacio, S., Beattie, E. C., and Abood, M. E. (2008). Altered presymp-tomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity. Eur. J. Neurosci. 27, 572-579. doi: 10.1111/j.1460-9568.2008.06041.x
131. Zhong, Z., Deane, R., Ali, Z., Parisi, M., Shapovalov, Y., O'banion, M. K., et al. (2008). ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat. Neurosci. 11, 420-422. doi: 10.1038/ nn2073